STTK Shattuck Labs Inc
Price (delayed)
$0.9836
Market cap
$47.11M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.49
Enterprise value
-$7.77M
Shattuck Labs, Inc. operates as a clinical-stage biotechnology company . The Company focuses on developing a novel class of biologic medicines for the treatment of cancer and autoimmune diseases. Shattuck
Highlights
Shattuck Labs's EPS has increased by 27% YoY and by 2.6% from the previous quarter
The debt has declined by 26% year-on-year and by 9% since the previous quarter
STTK's quick ratio is down by 28% YoY but it is up by 13% QoQ
The company's equity fell by 45% YoY and by 18% QoQ
STTK's revenue is down by 11% since the previous quarter
Key stats
What are the main financial stats of STTK
Market
Valuations
Earnings
Shares outstanding
47.9M
Market cap
$47.11M
Enterprise value
-$7.77M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.59
Price to sales (P/S)
8.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-1.36
Revenue
$5.72M
Gross profit
$5.72M
Operating income
-$80.57M
Net income
-$75.41M
EBIT
-$75.41M
EBITDA
-$71.15M
Free cash flow
-$60.57M
Per share
Balance sheet
Liquidity
EPS
-$1.49
EPS diluted
-$1.49
Free cash flow per share
-$1.19
Book value per share
$1.67
Revenue per share
$0.11
TBVPS
$1.79
Total assets
$91.05M
Total liabilities
$11.42M
Debt
$2.51M
Equity
$79.63M
Working capital
$70.3M
Debt to equity
0.03
Current ratio
8.88
Quick ratio
8.19
Net debt/EBITDA
0.77
Margins
Efficiency
Dividend
EBITDA margin
-1,243.7%
Gross margin
100%
Net margin
-1,318.1%
Operating margin
-1,408.3%
Return on assets
-63.1%
Return on equity
-72.6%
Return on invested capital
-150.4%
Return on capital employed
-91.8%
Return on sales
-1,318.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STTK stock price
How has the Shattuck Labs stock price performed over time
Intraday
16.28%
1 week
-16.64%
1 month
-25.48%
1 year
-88.71%
YTD
-18.71%
QTD
3.53%
Financial performance
How have Shattuck Labs's revenue and profit performed over time
Revenue
$5.72M
Gross profit
$5.72M
Operating income
-$80.57M
Net income
-$75.41M
Gross margin
100%
Net margin
-1,318.1%
The net margin has surged by 75% year-on-year but it has declined by 14% since the previous quarter
STTK's operating margin has surged by 75% year-on-year but it is down by 13% since the previous quarter
STTK's net income is up by 14% year-on-year
Shattuck Labs's operating income has increased by 12% YoY
Growth
What is Shattuck Labs's growth rate over time
Valuation
What is Shattuck Labs stock price valuation
P/E
N/A
P/B
0.59
P/S
8.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-1.36
Shattuck Labs's EPS has increased by 27% YoY and by 2.6% from the previous quarter
The stock's price to book (P/B) is 75% less than its 5-year quarterly average of 2.0 and 73% less than its last 4 quarters average of 1.9
The company's equity fell by 45% YoY and by 18% QoQ
STTK's price to sales (P/S) is 95% lower than its 5-year quarterly average of 149.7 and 88% lower than its last 4 quarters average of 63.1
STTK's revenue is down by 11% since the previous quarter
Efficiency
How efficient is Shattuck Labs business performance
Shattuck Labs's ROS has soared by 75% YoY but it has decreased by 14% from the previous quarter
The ROIC is down by 20% YoY
The ROE has declined by 17% since the previous quarter and by 15% year-on-year
STTK's return on assets is down by 16% since the previous quarter and by 12% year-on-year
Dividends
What is STTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STTK.
Financial health
How did Shattuck Labs financials performed over time
STTK's total assets is down by 43% year-on-year and by 19% since the previous quarter
STTK's current ratio is down by 29% year-on-year but it is up by 12% since the previous quarter
The debt is 97% smaller than the equity
The company's debt to equity has surged by 50% YoY
The company's equity fell by 45% YoY and by 18% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.